AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network.
AbbVie employees in Asia participated in its eighth annual Week of Possibilities (WOP) volunteering program, which unites employees around the world with a single purpose: to give back to local communities through volunteering.